There is good news for the country on the coronavirus front. Remdesivir, which President Trump took during his COVID therapy, has been approved by the FDA for treatment of the coronavirus.
Gilead Chairman and CEO Daniel O’Day commented on the big announcement, calling the development “incredible.”
“Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly to help find solutions to this global health crisis. It is incredible to be in the position today, less than one year since the earliest case reports of the disease now known as COVID-19, of having an FDA-approved treatment in the U.S. that is available for all appropriate patients in need,” they said.
The FDA said that remdesivir is suitable for use on patients age 12 years and older. The antiviral drug should “only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care.”
If you watched the debate last night, you know that Joe Biden and the Democrats will not be happy with this development. The Democrats and Biden are the party of fearmongering and shutdowns. Joe, like most Democrats, was all doom and gloom when talking about the coronavirus. President Trump was forward-looking and hopeful about how we can continue to live with this virus. In other words, President Trump is living with reality while the Democrats are living in a fantasyland where the president is responsible for virus deaths and can control viruses.
Biden mocked Trump’s approach to learning to continue life despite COVID.
“Learning to live with it? Come on. We’re dying with it,” Biden said. He has previously said that, if necessary, he would institute a new round of lockdowns. “I would shut it down,” he said in August. “I would listen to the scientists.”
He did not put the matter quite so bluntly on Thursday night, but he did make clear that, if elected president, he would exercise more control over how the nation manages the pandemic. Trump has largely left the matter to states while also undermining and mocking safety guidelines pertaining to mask mandates and social distancing.
“I’m going to shut down the virus, not the country,” Biden said.
See?! FANTASYLAND.
The study results for remdesivir are very positive. You better believe if I ever end up hospitalized with COVID, I’ll be asking my doctors about this drug.
On Thursday, the New England Journal of Medicine published results from the biotech company’s phase 3 trial, finding faster recovery times for adult treatment. The journal also pointed out that the drug was found to reduce the progression of the illness among severely ill patients who require oxygen therapy as part of their treatment.
CNBC reported that the drug, currently under the brand name Veklury, costs $2,340 for a five-day treatment course for people who are covered by government health programs. The five-day treatment costs $3,120 for U.S. patients with private health insurance.
“In August, the company said it planned to produce more than 2 million treatment courses of remdesivir by the end of the year and anticipated being able to make ‘several million more’ in 2021, adding it has increased the supply of the drug more than fiftyfold since January. Its manufacturing network now includes more than 40 companies in North America, Europe and Asia,” the outlet added.
Three cheers for remdesivir!
Please follow me on Facebook or Twitter @JCotrinski